Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 2 Effect of Tolvaptan and Placebo on VP Levels During the Course of the Trial
Histogram of changes in vasopressin (VP) levels from baseline to week 54 (in pg/ml) for patients randomized to tolvaptan (open bars) or to placebo (cross-hatched bars). Group changes were significant (Table 7). The histogram of the changes in individual patients shows a shift to the right, which is consistent with the significant increase in the patients randomized to tolvaptan, as shown in Table 7.
|
